Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests that hypothyroidism may cause alopecia areata.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

0.05% Betamethasone Dipropionate is the most effective topical treatment for alopecia areata.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Higher IL-17A levels indicate more severe alopecia areata.